These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23134698)

  • 1. Reporting guidelines for modelling studies.
    Bennett C; Manuel DG
    BMC Med Res Methodol; 2012 Nov; 12():168. PubMed ID: 23134698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of guidelines for good practice in decision-analytic modelling in health technology assessment.
    Philips Z; Ginnelly L; Sculpher M; Claxton K; Golder S; Riemsma R; Woolacoot N; Glanville J
    Health Technol Assess; 2004 Sep; 8(36):iii-iv, ix-xi, 1-158. PubMed ID: 15361314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review and critique of modelling in prioritising and designing screening programmes.
    Karnon J; Goyder E; Tappenden P; McPhie S; Towers I; Brazier J; Madan J
    Health Technol Assess; 2007 Dec; 11(52):iii-iv, ix-xi, 1-145. PubMed ID: 18031651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment.
    Philips Z; Bojke L; Sculpher M; Claxton K; Golder S
    Pharmacoeconomics; 2006; 24(4):355-71. PubMed ID: 16605282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for the health technology assessment of complex interventions: a protocol for a scoping review.
    Baghbanian A; Merlin T; Carter D; Wang S
    BMJ Open; 2020 Nov; 10(11):e039263. PubMed ID: 33257482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are adverse effects incorporated in economic models? An initial review of current practice.
    Craig D; McDaid C; Fonseca T; Stock C; Duffy S; Woolacott N
    Health Technol Assess; 2009 Dec; 13(62):1-71, 97-181, iii. PubMed ID: 20018146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model Structuring for Economic Evaluations of New Health Technologies.
    Haji Ali Afzali H; Bojke L; Karnon J
    Pharmacoeconomics; 2018 Nov; 36(11):1309-1319. PubMed ID: 30030816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
    Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
    JBI Libr Syst Rev; 2005; 3(6):1-33. PubMed ID: 27819973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-criteria decision analysis for health technology assessment: addressing methodological challenges to improve the state of the art.
    Oliveira MD; Mataloto I; Kanavos P
    Eur J Health Econ; 2019 Aug; 20(6):891-918. PubMed ID: 31006056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of economic evaluations in NHS decision-making: a review and empirical investigation.
    Williams I; McIver S; Moore D; Bryan S
    Health Technol Assess; 2008 Apr; 12(7):iii, ix-x, 1-175. PubMed ID: 18373906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    Value Health; 2013; 16(2):231-50. PubMed ID: 23538175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic management strategies for adults and children with minor head injury: a systematic review and an economic evaluation.
    Pandor A; Goodacre S; Harnan S; Holmes M; Pickering A; Fitzgerald P; Rees A; Stevenson M
    Health Technol Assess; 2011 Aug; 15(27):1-202. PubMed ID: 21806873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of modelling in prioritising and planning clinical trials.
    Chilcott J; Brennan A; Booth A; Karnon J; Tappenden P
    Health Technol Assess; 2003; 7(23):iii, 1-125. PubMed ID: 14499052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting guidelines for survey research: an analysis of published guidance and reporting practices.
    Bennett C; Khangura S; Brehaut JC; Graham ID; Moher D; Potter BK; Grimshaw JM
    PLoS Med; 2010 Aug; 8(8):e1001069. PubMed ID: 21829330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
    Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
    Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for multi-model comparisons of the impact of infectious disease interventions.
    den Boon S; Jit M; Brisson M; Medley G; Beutels P; White R; Flasche S; Hollingsworth TD; Garske T; Pitzer VE; Hoogendoorn M; Geffen O; Clark A; Kim J; Hutubessy R
    BMC Med; 2019 Aug; 17(1):163. PubMed ID: 31422772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to develop cost-conscious guidelines.
    Eccles M; Mason J
    Health Technol Assess; 2001; 5(16):1-69. PubMed ID: 11427188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.